Histofy and Fundación MD Anderson Cancer Center España announce exclusive partnership to advance AI-driven cancer diagnostics with support of Smart In Media
Coventry, UK / Madrid, Spain – 4 June 2025
Histofy, a leading pathology AI company focused on transforming cancer diagnostics, today announced a landmark exclusive partnership with Fundación MD Anderson Cancer Center España, leading institution in oncology research in Europe, and Smart in Media Iberia SLU, a leading company in Digital Pathology to collaborate on the development of cutting-edge artificial intelligence (AI) solutions in digital pathology.
This collaboration marks a major milestone in the application of AI to cancer care. Through the partnership, Histofy will gain time-limited exclusive access to one of the most comprehensive and high-quality collections of digitized pathology slides and clinical data in Europe. This access will significantly accelerate the development and validation of AI algorithms designed to enhance diagnostic accuracy, reduce time to diagnosis, and support more personalized treatment pathways for patients.